LONDON, December 21 /PRNewswire/ --

- Prenatal Omega 3 Supplementation has Long-Term Health Benefits for Unborn Babies

A new longitudinal study has shown that the benefits of prenatal omega 3 supplementation extend to the child's motor function in later life(1). The study, conducted in the Netherlands over 7 years, followed 300 children and related their motor abilities back to umbilical blood samples, which showed the levels of omega 3 essential fatty acid, Docosahexaenoic Acid (DHA) at the time of birth.

LONDON, December 21 /PRNewswire/ --

- Virgin Active Offers Healthy Advice on Joining Gyms in 2008

At a time when it is feared that mortgage debts are rising as quickly as obesity levels, Virgin Active has come up with suggestions to help people make an informed investment when joining a health club. The ideas that follow will enable individuals to remain financially sensible whilst trying to combat a tightening pinch around their waist lines as well as their wallets.

Top tips:

- Make sure that a sales representative fully explains the terms and conditions to you before you sign. If you don't have time, take the contract home and go through it at your leisure so you know what you are committing to.

MELBOURNE, Australia, December 21 /PRNewswire/ --

Starpharma Holdings Limited (ASX:SPL, OTC: SPHRY), developer of VivaGel(R) vaginal microbicide today welcomed a decision by the US FDA this week requiring makers of products containing nonoxynol 9 (N9) to carry a warning that the products do not protect against sexually transmitted diseases, including HIV/AIDS and that the use of N-9 products is associated with an increased risk of HIV.

Starpharma's VivaGel(R) is a vaginal gel, being developed to protect women from HIV and HSV-2 (genital herpes) during sex. VivaGel(R) does not use N9. VivaGel(R) is currently in mid-stage clinical trials in the US and Kenya to add to its portfolio of safety data before embarking on population-based efficacy testing.

SAN MATEO, California, December 21 /PRNewswire/ -- Bizanga, the global company behind the most scalable and full-featured e-mail and message processing platform, today announced the appointment of Peter Zadrozny as Vice President of Product Management. A 25-year computer industry veteran, Zadrozny will guide the implementation of the company's product roadmap for its traditional carrier business as well as new ventures.

"Peter Zadrozny is a welcome addition to the Bizanga team," according to Marc Sheldon, Chief Marketing Officer for Bizanga. "His leadership and depth of experience will ensure the continued pre-eminence of Bizanga's platform as we build on our core technology to meet the evolving needs of carrier clients and move into new markets."

MALVERN, Pennsylvania, December 21 /PRNewswire/ --

Solstice Neurosciences, Inc. ("Solstice") announced the appointment of Dennis L. Smith as President and Chief Executive Officer. He will also continue to serve as Chairman to its Board of Directors.

Mr. Smith brings unique specialty pharmaceutical industry experience and expertise to Solstice that will be invaluable in providing guidance, leadership, and strategies for growth as the company continues to broaden its product portfolio globally and map its strategy.

GENEVA, Switzerland, December 21 /PRNewswire/ -- WISeKey and Publicis Live are inviting their partners and customers to join "Hightrusted.com ", a highly trusted social network platform. This platform provides a high-level digital identity solution, which verifies and authenticates the user's identity, thus enabling a safer virtual world and bringing protection and peace-of-mind to users and their trustees.

WISeKey furnishes secure solutions which implement an extra layer in social networking infrastructures, using techniques such as back-end validation procedures which verify attributes like age and real-world identity.

This cooperation will combine virtual access to the Internet with physical access to events and conferences.